Your institution may have access to this item. Find your institution then sign in to continue.
Title
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.
Authors
Antonini, M G; Babudieri, S; Maida, I; Baiguera, C; Zanini, B; Fenu, L; Dettori, G; Manno, D; Mura, M S; Carosi, G; Puoti, M
Abstract
Combination therapy with pegylated interferon (peginterferon) plus ribavirin is associated with several side effects, including neutropenia and infection.